Imidapril-induced eosinophilic pleurisy. Case report and review of the literature.
We describe an unusual case of a patient with eosinophilic pleurisy associated with long-term administration of imidapril, an angiotensin-converting enzyme inhibitor (ACEI). An 81-year-old woman who had been given imidapril for the treatment of essential hypertension was admitted to our hospital for investigation of persistent low-grade fever, dry cough and difficulty in breathing. Left-sided eosinophilic pleurisy was diagnosed based on eosinophilic pleural effusion and peripheral eosinophilia. Soon after administration of imidapril was discontinued, her clinical symptoms subsided, and there was improvement in both diagnostic imaging and laboratory findings. So far, to our knowledge, this is the first reported case in which ACEI induced eosinophilic pleurisy.
Yoshida
Hiromichi
H
Internal Medicine, San-ai Soga Memorial Hospital, Chiba, Japan. yosh915@green.ocn.ne.jp
Hasegawa
Ritsuko
R
Hayashi
Haruyuki
H
Irie
Yasubumi
Y
D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D004802:Eosinophilia / Q000139:chemically induced*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D048289:Imidazolidines / Q000009:adverse effects*; D008171:Lung Diseases / Q000139:chemically induced; D010998:Pleurisy / Q000139:chemically induced*
D000806:Angiotensin-Converting Enzyme Inhibitors; D048289:Imidazolidines; C065166:imidapril